Bullseye Investment Management’s Invesco High Income 2023 Target Term Fund Common Shares of Beneficial Interest, No par value per share IHIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-736,281
Closed -$5.46M 51
2023
Q2
$5.46M Sell
736,281
-240,500
-25% -$1.83M 3.97% 8
2023
Q1
$7.63M Buy
976,781
+70,414
+8% +$571K 5.58% 5
2022
Q4
$7.29M Buy
+906,367
New +$7.43M 6.03% 1

Other funds holding IHIT

Bullseye Investment Management's IHIT Position: Q3 2023 in Review

Bullseye Investment Management sold out of Invesco High Income 2023 Target Term Fund Common Shares of Beneficial Interest, No par value per share (IHIT) in Q3 2023, closing a stake of 736,281 shares — an estimated $5.46M sold.

Bullseye Investment Management first reported a position in IHIT in Q4 2022 and held it in 3 quarters. The position peaked at $7.63M in Q1 2023. 41 funds tracked by Wall St. Rank hold IHIT as of Q3 2023.

  • Bullseye Investment Management reported no remaining Invesco High Income 2023 Target Term Fund Common Shares of Beneficial Interest, No par value per share position as of Q3 2023 after selling out during the quarter.
  • Bullseye Investment Management sold 736,281 Invesco High Income 2023 Target Term Fund Common Shares of Beneficial Interest, No par value per share shares in Q3 2023, an estimated $5.46M.
  • Bullseye Investment Management first reported a position in Invesco High Income 2023 Target Term Fund Common Shares of Beneficial Interest, No par value per share in Q4 2022 and held it in 3 quarters.
  • Bullseye Investment Management's Invesco High Income 2023 Target Term Fund Common Shares of Beneficial Interest, No par value per share position peaked at $7.63M in Q1 2023.
  • 41 funds tracked by Wall St. Rank held Invesco High Income 2023 Target Term Fund Common Shares of Beneficial Interest, No par value per share as of Q3 2023.

Based on Bullseye Investment Management's 13F filing for Q3 2023, filed 14 Nov 2023.